Found: 102
Select item for more details and to access through your institution.
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1459502
- By:
- Publication type:
- Article
Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00528-8
- By:
- Publication type:
- Article
Multiple sclerosis: Immunopathological heterogeneity and its implications.
- Published in:
- European Journal of Immunology, 2022, v. 52, n. 6, p. 869, doi. 10.1002/eji.202149757
- By:
- Publication type:
- Article
The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone.
- Published in:
- Multiple Sclerosis (13524585), 2006, v. 12, n. 4, p. 487, doi. 10.1191/135248505ms1322oa
- By:
- Publication type:
- Article
Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis (13524585), 2004, v. 10, n. 6, p. 618, doi. 10.1191/1352458504ms1097oa
- By:
- Publication type:
- Article
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
- Published in:
- Nature Medicine, 2014, v. 20, n. 3, p. 272, doi. 10.1038/nm.3485
- By:
- Publication type:
- Article
Consensus guidelines to perform lumbar puncture for CSF sampling in patients with neurological conditions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P384, doi. 10.1016/j.jalz.2015.06.313
- By:
- Publication type:
- Article
Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis<sup>1</sup> / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2010, v. 34, n. 1, p. 1, doi. 10.1515/JLM.2010.001
- By:
- Publication type:
- Article
Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 950, doi. 10.1177/13524585211053001
- By:
- Publication type:
- Article
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 71, doi. 10.1177/13524585211010082
- By:
- Publication type:
- Article
Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 9, p. 1455, doi. 10.1177/1352458520980141
- By:
- Publication type:
- Article
The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 913, doi. 10.1177/1352458520988148
- By:
- Publication type:
- Article
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1658, doi. 10.1177/1352458519877810
- By:
- Publication type:
- Article
Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 11, p. 1535, doi. 10.1177/1352458518786055
- By:
- Publication type:
- Article
NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 11, p. 1507, doi. 10.1177/1352458517739137
- By:
- Publication type:
- Article
Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 3, p. 322, doi. 10.1177/1352458517698052
- By:
- Publication type:
- Article
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 3, p. 301, doi. 10.1177/1352458517697830
- By:
- Publication type:
- Article
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 7, p. 937, doi. 10.1177/1352458516667564
- By:
- Publication type:
- Article
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, p. 18, doi. 10.1177/1352458516650739
- By:
- Publication type:
- Article
Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled – MS arising during Tocilizumab therapy for rheumatoid arthritis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 2, p. 257, doi. 10.1177/1352458515623863
- By:
- Publication type:
- Article
Should we systematically test patients with clinically isolated syndrome for auto-antibodies?
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1802, doi. 10.1177/1352458515575338
- By:
- Publication type:
- Article
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1498, doi. 10.1177/1352458514566418
- By:
- Publication type:
- Article
Interferon-beta affects mitochondrial activity in CD4<sup>+</sup> lymphocytes: Implications for mechanism of action in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1262, doi. 10.1177/1352458514561909
- By:
- Publication type:
- Article
Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 12, p. 1602, doi. 10.1177/1352458514527863
- By:
- Publication type:
- Article
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber’s hereditary optic neuropathy: clinical commentary.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 13, p. 1802, doi. 10.1177/1352458513488232
- By:
- Publication type:
- Article
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 959, doi. 10.1177/1352458511432741
- By:
- Publication type:
- Article
EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 5, p. 605, doi. 10.1177/1352458511426816
- By:
- Publication type:
- Article
Angiogenin in the Neurogenic Subventricular Zone After Stroke.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.662235
- By:
- Publication type:
- Article
Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134414
- By:
- Publication type:
- Article
Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082796
- By:
- Publication type:
- Article
Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060994
- By:
- Publication type:
- Article
Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023634
- By:
- Publication type:
- Article
Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms.
- Published in:
- PLoS ONE, 2008, v. 3, n. 10, p. 1, doi. 10.1371/journal.pone.0003490
- By:
- Publication type:
- Article
mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis.
- Published in:
- PLoS ONE, 2008, v. 3, n. 2, p. 1, doi. 10.1371/journal.pone.0001530
- By:
- Publication type:
- Article
Pharmacogenomics and Multiple Sclerosis: Moving Toward Individualized Medicine.
- Published in:
- Current Neurology & Neuroscience Reports, 2011, v. 11, n. 5, p. 484, doi. 10.1007/s11910-011-0211-1
- By:
- Publication type:
- Article
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2008, v. 255, n. 8, p. 1136, doi. 10.1007/s00415-008-0855-1
- By:
- Publication type:
- Article
TNF–α converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis.
- Published in:
- Journal of Neurology, 2006, v. 253, n. 6, p. 701, doi. 10.1007/s00415-006-0090-6
- By:
- Publication type:
- Article
Lambert–Eaton Myasthenic syndrome associated with sarcoidosis.
- Published in:
- Journal of Neurology, 2005, v. 252, n. 9, p. 1127, doi. 10.1007/s00415-005-0807-y
- By:
- Publication type:
- Article
Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI.
- Published in:
- Journal of Magnetic Resonance Imaging, 2024, v. 60, n. 1, p. 258, doi. 10.1002/jmri.29046
- By:
- Publication type:
- Article
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
- Published in:
- Stem Cells Translational Medicine, 2015, v. 4, n. 3, p. 252, doi. 10.5966/sctm.2014-0133
- By:
- Publication type:
- Article
A Polymorphism Within the MBP Gene Is Associated With a Higher Relapse Number in Male Patients of Multiple Sclerosis.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00771
- By:
- Publication type:
- Article
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 4, p. 397, doi. 10.1001/jamaneurol.2023.0010
- By:
- Publication type:
- Article
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 2, p. 151, doi. 10.1001/jamaneurol.2022.4655
- By:
- Publication type:
- Article